Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction

American Heart Journal

Volumn 142, Issue 4, 2001, Pages 617-623

  McFarlane, Allan ^a   Kamath, Markad V ^a   Fallen, Ernest L ^a   Malcolm, Victoria ^a   Cherian, Finu ^a   Norman, Geoff ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SERTRALINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTONOMIC INNERVATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART AUTOMATICITY; HEART RATE VARIABILITY; HOSPITAL DISCHARGE; HUMAN; MALE; MODEL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SURVIVAL; TIME;

EID: 0034806969     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.116766     Document Type: Article

References (34)

1. Lifetime and 12 month prevalence of DSM III-R psychiatric disorders in the United States
2. Depression and myocardial infarction: Implications for medical prognosis and options for treatment
3. The relationship of depression to cordiovascular disease
4. Depression following myocardial infarction: Impact on 6 month survival
5. Depression and the heart
6. Drugs for affective (mood) disorders
7. The serotonin hypothesis of depression
8. Power spectral analysis of heart rate variability: A non-invasive signature of cardiac autonomic function
9. Decreased heart rate voriability and its association with mortality after myocardial infarction
10. Are affective disorders associated with alterations in heart rate variability?
11. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease
12. Heart rate variability in patients with major depression
13. Time course of recovery of heart period variability after myocardial infarction
14. Heart rate variability as an index of sympathovagal interaction after acute myocardial infarction
15. A self-report scale to diagnose major depressive disorder
16. The Inventory to Diagnose Depression (IDD): A self report scale to diagnose major depressive disorder
17. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure
18. A growth curve approach to the measurement of change
19. Biobehavioural variables and mortality or cardiac arrest in the cardiac arrhythmia pilot study (CAPS)
20. The nature and course of depression following myocardial infarction
21. Depression and 18 month prognosis after myocardial infarction
22. Depression following myocardial infarction: A one year longitudinal study
23. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation
24. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability
25. Association of depression with reduced heart rate variability in coronary artery disease
26. Increases in heart rate variability with successful treatment in patients with major depressive disorder
27. Autonomic correlates of antidepressant treatment using heart rate variability analysis
28. Paroxetine increases heart rate variability in panic disorder
29. Stability over time of variables measuring heart rate variability in normal subjects
30. Effect of atenolol and diltiazem on heart rate variability in normal persons
31. Diurnal variations in neurocardiac rhythms in acute myocardial infarction
32. Sertraline does not alter the beta adrenergic blocking activity of atenolol in healthy mate volunteers
33. Standards of measurement, physiological interpretation and clinical use
34. An open label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT trial)